Alliance Pharma logo

APH - Alliance Pharma Share Price

87p 0.6  0.7%

Last Trade - 24/01/20

Sector
Healthcare
Size
Mid Cap
Market Cap £460.6m
Enterprise Value £538.2m
Revenue £129.8m
Position in Universe 592nd / 1830
Bullish
Bearish
Unlock APH Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

APH Revenue Unlock APH Revenue

Net Income

APH Net Income Unlock APH Revenue

Normalised EPS

APH Normalised EPS Unlock APH Revenue

PE Ratio Range

APH PE Ratio Range Unlock APH Revenue

Dividend Yield Range

APH Dividend Yield Range Unlock APH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
APH EPS Forecasts Unlock APH Revenue
Profile Summary

Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international. The Company's therapeutic areas of focus include cardiovascular, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynecology, oral health, oncology, stoma care, toxicology and travel health. The Company's product categories include prescription only medicines, over the counter medications, medical devices, cosmetics and nutritional supplements. The Company's products include SkinSafe, Lift Plus, AbsorbaGel, DeoGel, LaVera, ClearWay, Gelclair, ImmuCyst 81mg, Hydromol, MacuShield, Lypsyl, Anbesol Adult Strength Gel, MolluDab and Ashton & Parsons Infants' Powders.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated June 26, 2001
Public Since November 22, 2001
No. of Shareholders: n/a
No. of Employees: 210
Sector Healthcare
Industry Pharmaceuticals
Index FTSE Aim All Share , FTSE Aim 100 , FTSE Intl-aim UK 50 ,
Exchange London Stock Exchange (AIM)
Shares in Issue 529,402,619
Free Float (0.0%)
Eligible for
ISAs
SIPPs
APH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for APH
Upcoming Events for APH
Tuesday 24th March, 2020
Full Year 2019 Alliance Pharma PLC Earnings Release
Similar to APH
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.